查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1555617

薄膜式氧供給設備的全球市場:產業分析，規模，佔有率，成長，趨勢，預測(2024～2032年)

Membrane Oxygenators Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

本報告發表了對全球膜供氧市場的深入研究，並對關鍵市場動態進行了廣泛分析，包括市場推動因素、趨勢、機會和課題。該報告提供了對市場結構和未來軌蹟的詳細見解。

主要的洞察

  • 薄膜供氧裝置市場規模（2024年）：1.421億美元
  • 市場預測金額（2033 年）：1.66 億美元
  • 全球市場成長率（2024-2033 年複合年增長率）：2.0%

膜式供氧裝置市場：調查範圍

膜氧合裝置由於能夠增強呼吸衰竭患者的氣體交換而越來越多地用於重症監護和心臟手術。這些設備在體外生命支持 (ECLS) 和體外膜氧合 (ECMO) 系統中發揮關鍵作用，這使得它們在醫療保健環境中至關重要。該市場的主要驅動力是呼吸系統疾病和心臟病患病率的上升、對 ECMO 手術的需求不斷增加以及各地區醫療基礎設施的進步。

市場推動因素：

全球膜氧合設備市場受到幾個關鍵因素的推動。其中包括慢性呼吸系統疾病和心血管疾病的盛行率增加，需要使用先進的氧氣輸送系統。此外，人們越來越接受 ECMO 作為重症監護環境中的救生幹預措施，也對市場成長做出了重大貢獻。膜氧合裝置設計的技術進步以及這些系統在新生兒和兒科醫學中的日益採用也支持了市場的擴張。

市場阻礙因素：

儘管成長前景廣闊，但膜氧供應市場仍面臨一定的課題。 ECMO 程序和設備相關的高成本可能會阻礙其廣泛使用，特別是在發展中國家。此外，這些系統很複雜，需要專門的醫務人員來操作，造成了市場進入障礙。對 ECMO 及其在某些地區的應用的認識不足也限制了市場的成長。

市場機會：

由於持續的技術創新和 ECMO 系統在各種醫療保健環境中的使用不斷增加，膜氧合設備市場提供了巨大的成長機會。便攜式、用戶友好的氧氣輸送設備的開發預計將增加這些設備在緊急情況和家庭護理環境中的可及性。此外，越來越注重透過先進的醫療幹預措施改善患者的治療結果，這為市場成長開闢了新的途徑，特別是在醫療基礎設施不斷發展的新興市場。

本報告涵蓋的主要問題

  • 推動全球膜氧供應市場的關鍵因素是什麼？
  • 哪裡對膜式供氧裝置的需求量最大？
  • 技術進步如何影響膜氧供應市場？
  • 誰是膜供氧市場的主要參與者？
  • 膜式供氧裝置市場的新趨勢與未來前景如何？

目錄

第1章 摘要整理

第2章 市場概要

  • 市場範圍/分類
  • 市場定義/範圍/限制

第3章 市場背景

  • 市場動態
  • 情勢預測
  • 法規情形

第4章 全球薄膜式氧供給設備市場分析

  • 過去的市場規模金額(100萬美元)分析，2019～2023年
  • 現在及未來市場規模金額(100萬美元)預測，2024～2032年
    • 與前一年同期比較成長趨勢分析
    • 絕對的商機

第5章 全球薄膜式氧供給設備市場分析:各產品類型

  • 簡介/主要調查結果
  • 過去的市場規模金額(100萬美元)分析，各產品類型，2019～2023年
  • 現在及未來市場規模金額(100萬美元)分析與預測，各產品類型，2024～2032年
    • 中空纖維濾膜氧供給設備
    • 片狀濾膜氧供給設備
  • 與前一年同期比較成長趨勢分析，各產品類型，2019～2023年
  • 絕對的商機，各產品類型，2024～2032年

第6章 全球薄膜式氧供給設備市場分析:各年齡層

  • 簡介/主要調查結果
  • 過去的市場規模金額(100萬美元)分析，各年齡層，2019～2023年
  • 現在及未來市場規模金額(100萬美元)分析與預測，各年齡層，2024～2032年
    • 新生兒
    • 兒童
    • 大人
  • 與前一年同期比較成長趨勢分析，各年齡層，2019～2023年
  • 絕對的商機，各年齡層，2024～2032年

第7章 全球薄膜式氧供給設備市場分析:各用途

  • 簡介/主要調查結果
  • 過去的市場規模金額(100萬美元)分析，各用途，2019～2023年
  • 現在及未來市場規模金額(100萬美元)分析與預測，各用途，2024～2032年
    • 呼吸系統
      • 呼吸不全
      • 肺動脈栓塞
      • 急性呼吸促拍症候群
      • 肺炎
      • COVID-19
    • 心臟
      • 急性心肌梗塞
      • 心肌炎
      • 移植後併發症
      • 非補償性心肌病
      • 心源性休克
    • ECPR
  • 與前一年同期比較成長趨勢分析，各用途，2019～2023年
  • 絕對的商機，各用途，2024～2032年

第8章 全球薄膜式氧供給設備市場分析:各地區

  • 簡介/主要調查結果
  • 過去的市場規模金額(100萬美元)分析，各地區，2019～2023年
  • 現在及未來市場規模金額(100萬美元)分析與預測，各地區，2024～2032年
    • 北美
    • 南美
    • 歐洲
    • 東亞
    • 南亞
    • 大洋洲
    • 中東·非洲
  • 市場魅力分析:各地區

第9章 北美的薄膜式氧供給設備市場分析:各國

第10章 南美的薄膜式氧供給設備市場分析:各國

第11章 歐洲的薄膜式氧供給設備市場分析:各國

第12章 東亞的薄膜式氧供給設備市場分析:各國

第13章 南亞的薄膜式氧供給設備市場分析:各國

第14章 大洋洲的薄膜式氧供給設備市場分析:各國

第15章 中東·非洲的薄膜式氧供給設備市場分析:各國

第16章 主要國家的薄膜式氧供給設備市場分析

  • 美國
  • 加拿大
  • 巴西
  • 墨西哥
  • 阿根廷
  • 德國
  • 義大利
  • 法國
  • 英國
  • 西班牙
  • 俄羅斯
  • 荷比盧三國
  • 中國
  • 日本
  • 韓國
  • 印度
  • 泰國
  • 馬來西亞
  • 印尼
  • 澳洲
  • 紐西蘭
  • GCC各國

第17章 市場結構分析

  • 競爭儀表板
  • 競爭基準
  • 主要企業的市場佔有率分析

第18章 競爭分析

  • 競爭詳細內容
    • MicroPort Scientific Corporation
    • Nipro Medical Corporation
    • Medtronic
    • Fresenius SE &Co KGaA
    • Terumo Medical Corporation
    • Getinge AB

第19章 所使用的假設和縮寫

第20章 調查手法

簡介目錄
Product Code: PMRREP33254

Persistence Market Research has recently published a detailed report on the global Membrane Oxygenators Market, offering an extensive analysis of key market dynamics, including drivers, trends, opportunities, and challenges. The report presents in-depth insights into the structure of the market and its future trajectory.

Key Insights:

  • Membrane Oxygenators Market Size (2024E): USD 142.1 Mn
  • Projected Market Value (2033F): USD 166 Mn
  • Global Market Growth Rate (CAGR 2024 to 2033): 2.0%

Membrane Oxygenators Market - Report Scope:

Membrane oxygenators are increasingly being used in critical care and cardiac surgeries due to their ability to facilitate gas exchange for patients with respiratory failure. These devices play a vital role in extracorporeal life support (ECLS) and extracorporeal membrane oxygenation (ECMO) systems, making them indispensable in healthcare settings. The market is primarily driven by the rising incidence of respiratory and cardiac disorders, the growing demand for ECMO procedures, and advancements in healthcare infrastructure across various regions.

Market Growth Drivers:

The global membrane oxygenators market is fueled by several important factors. These include the increasing prevalence of chronic respiratory and cardiovascular diseases, which necessitate the use of advanced oxygenation systems. Additionally, the growing acceptance of ECMO as a lifesaving intervention in critical care settings is a major contributor to market growth. Technological advancements in membrane oxygenator design and the rising adoption of these systems in neonatal and pediatric care further support market expansion.

Market Restraints:

Despite its promising growth prospects, the membrane oxygenators market faces certain challenges. High costs associated with ECMO procedures and devices can hinder their widespread adoption, particularly in developing countries. Furthermore, the complexity of these systems and the need for specialized healthcare professionals to operate them add to the barriers to market entry. Limited awareness about ECMO and its applications in certain regions also restricts market growth.

Market Opportunities:

The membrane oxygenators market presents significant growth opportunities driven by ongoing technological innovations and the expanding use of ECMO systems across various healthcare settings. The development of portable and user-friendly oxygenators is expected to increase the accessibility of these devices in emergency and home care settings. Moreover, the rising focus on improving patient outcomes through advanced medical interventions opens up new avenues for market growth, particularly in emerging markets where healthcare infrastructure is evolving.

Key Questions Answered in the Report:

  • What are the main factors driving the global membrane oxygenators market?
  • Which regions are witnessing the highest demand for membrane oxygenators?
  • How are technological advancements impacting the membrane oxygenators market?
  • Who are the leading players in the membrane oxygenators market, and what strategies are they employing to maintain their market position?
  • What are the emerging trends and future prospects in the membrane oxygenators market?

Competitive Intelligence and Business Strategy:

Leading players in the global membrane oxygenators market, such as Medtronic, Terumo Cardiovascular Systems, and Getinge AB, are focusing on innovation, product development, and strategic partnerships to stay competitive. These companies are investing in research and development to enhance device efficiency, improve patient outcomes, and expand their product portfolios. Collaborations with healthcare institutions and the introduction of cost-effective solutions for critical care are key strategies driving market growth. Additionally, meeting stringent regulatory requirements and maintaining high product quality remain priorities for companies in this space, ensuring sustained growth in the global membrane oxygenators market.

Key Companies Profiled:

  • MicroPort Scientific Corporation
  • Nipro Medical Corporation
  • Medtronic
  • Fresenius SE & Co KGaA
  • Terumo Medical Corporation
  • Getinge AB

Market Segments Covered in Membrane Oxygenators Market Analysis

By Type

  • Hollow Fiber Membrane Oxygenators
  • Flat Sheet Membrane Oxygenators

By Age Group

  • Neonates
  • Pediatrics
  • Adults

By Application

  • Respiratory
  • Cardiac
  • ECPR

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa(MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand-side Trends
  • 1.3. Supply-side Trends
  • 1.4. Technology Roadmap Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Background

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity
    • 3.1.4. Trends
  • 3.2. Scenario Forecast
    • 3.2.1. Demand in Optimistic Scenario
    • 3.2.2. Demand in Likely Scenario
    • 3.2.3. Demand in Conservative Scenario
  • 3.3. Regulatory Landscape
    • 3.3.1. By Key Regions
    • 3.3.2. By Key Countries

4. Global Membrane Oxygenators Market Analysis 2019-2023 and Forecast, 2024-2032

  • 4.1. Historical Market Size Value (US$ Mn) Analysis, 2019-2023
  • 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2024-2032
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Global Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Product Type

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2019-2023
  • 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2024-2032
    • 5.3.1. Hollow Fiber Membrane Oxygenators
    • 5.3.2. Flat Sheet Membrane Oxygenators
  • 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2019-2023
  • 5.5. Absolute $ Opportunity Analysis By Product Type, 2024-2032

6. Global Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Age Group

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size Value (US$ Mn) Analysis By Age Group, 2019-2023
  • 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Age Group, 2024-2032
    • 6.3.1. Neonates
    • 6.3.2. Pediatrics
    • 6.3.3. Adults
  • 6.4. Y-o-Y Growth Trend Analysis By Age Group, 2019-2023
  • 6.5. Absolute $ Opportunity Analysis By Age Group, 2024-2032

7. Global Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Application

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2019-2023
  • 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2024-2032
    • 7.3.1. Respiratory
      • 7.3.1.1. Respiratory failure
      • 7.3.1.2. Pulmonary embolism
      • 7.3.1.3. Acute respiratory distress syndrome
      • 7.3.1.4. Pneumonia
      • 7.3.1.5. COVID-19
    • 7.3.2. Cardiac
      • 7.3.2.1. Acute myocardial infarction
      • 7.3.2.2. Myocarditis
      • 7.3.2.3. Post-transplant complications
      • 7.3.2.4. Decompensated cardiomyopathy
      • 7.3.2.5. Cardiogenic shock
    • 7.3.3. ECPR
  • 7.4. Y-o-Y Growth Trend Analysis By Application, 2019-2023
  • 7.5. Absolute $ Opportunity Analysis By Application, 2024-2032

8. Global Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Region

  • 8.1. Introduction
  • 8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2019-2023
  • 8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2024-2032
    • 8.3.1. North America
    • 8.3.2. Latin America
    • 8.3.3. Europe
    • 8.3.4. East Asia
    • 8.3.5. South Asia
    • 8.3.6. Oceania
    • 8.3.7. MEA
  • 8.4. Market Attractiveness Analysis By Region

9. North America Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 9.2.1. By Country
      • 9.2.1.1. U.S.
      • 9.2.1.2. Canada
    • 9.2.2. By Product Type
    • 9.2.3. By Age Group
    • 9.2.4. By Application
  • 9.3. Market Attractiveness Analysis
    • 9.3.1. By Country
    • 9.3.2. By Product Type
    • 9.3.3. By Age Group
    • 9.3.4. By Application
  • 9.4. Key Takeaways

10. Latin America Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 10.2.1. By Country
      • 10.2.1.1. Brazil
      • 10.2.1.2. Mexico
      • 10.2.1.3. Argentina
      • 10.2.1.4. Rest of Latin America
    • 10.2.2. By Product Type
    • 10.2.3. By Age Group
    • 10.2.4. By Application
  • 10.3. Market Attractiveness Analysis
    • 10.3.1. By Country
    • 10.3.2. By Product Type
    • 10.3.3. By Age Group
    • 10.3.4. By Application
  • 10.4. Key Takeaways

11. Europe Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 11.2.1. By Country
      • 11.2.1.1. Germany
      • 11.2.1.2. Italy
      • 11.2.1.3. France
      • 11.2.1.4. U.K.
      • 11.2.1.5. Spain
      • 11.2.1.6. Russia
      • 11.2.1.7. BENELUX
      • 11.2.1.8. Rest of Europe
    • 11.2.2. By Product Type
    • 11.2.3. By Age Group
    • 11.2.4. By Application
  • 11.3. Market Attractiveness Analysis
    • 11.3.1. By Country
    • 11.3.2. By Product Type
    • 11.3.3. By Age Group
    • 11.3.4. By Application
  • 11.4. Key Takeaways

12. East Asia Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 12.2.1. By Country
      • 12.2.1.1. China
      • 12.2.1.2. Japan
      • 12.2.1.3. South Korea
    • 12.2.2. By Product Type
    • 12.2.3. By Age Group
    • 12.2.4. By Application
  • 12.3. Market Attractiveness Analysis
    • 12.3.1. By Country
    • 12.3.2. By Product Type
    • 12.3.3. By Age Group
    • 12.3.4. By Application
  • 12.4. Key Takeaways

13. South Asia Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 13.2.1. By Country
      • 13.2.1.1. India
      • 13.2.1.2. Thailand
      • 13.2.1.3. Malaysia
      • 13.2.1.4. Indonesia
      • 13.2.1.5. Rest of South Asia
    • 13.2.2. By Product Type
    • 13.2.3. By Age Group
    • 13.2.4. By Application
  • 13.3. Market Attractiveness Analysis
    • 13.3.1. By Country
    • 13.3.2. By Product Type
    • 13.3.3. By Age Group
    • 13.3.4. By Application
  • 13.4. Key Takeaways

14. Oceania Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 14.2.1. By Country
      • 14.2.1.1. Australia
      • 14.2.1.2. New Zealand
    • 14.2.2. By Product Type
    • 14.2.3. By Age Group
    • 14.2.4. By Application
  • 14.3. Market Attractiveness Analysis
    • 14.3.1. By Country
    • 14.3.2. By Product Type
    • 14.3.3. By Age Group
    • 14.3.4. By Application
  • 14.4. Key Takeaways

15. MEA Membrane Oxygenators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 15.2.1. By Country
      • 15.2.1.1. GCC
      • 15.2.1.2. Rest of MEA
    • 15.2.2. By Product Type
    • 15.2.3. By Age Group
    • 15.2.4. By Application
  • 15.3. Market Attractiveness Analysis
    • 15.3.1. By Country
    • 15.3.2. By Product Type
    • 15.3.3. By Age Group
    • 15.3.4. By Application
  • 15.4. Key Takeaways

16. Key Countries Membrane Oxygenators Market Analysis

  • 16.1. U.S.
    • 16.1.1. Pricing Analysis
    • 16.1.2. Market Share Analysis, 2024
      • 16.1.2.1. By Product Type
      • 16.1.2.2. By Age Group
      • 16.1.2.3. By Application
  • 16.2. Canada
    • 16.2.1. Pricing Analysis
    • 16.2.2. Market Share Analysis, 2024
      • 16.2.2.1. By Product Type
      • 16.2.2.2. By Age Group
      • 16.2.2.3. By Application
  • 16.3. Brazil
    • 16.3.1. Pricing Analysis
    • 16.3.2. Market Share Analysis, 2024
      • 16.3.2.1. By Product Type
      • 16.3.2.2. By Age Group
      • 16.3.2.3. By Application
  • 16.4. Mexico
    • 16.4.1. Pricing Analysis
    • 16.4.2. Market Share Analysis, 2024
      • 16.4.2.1. By Product Type
      • 16.4.2.2. By Age Group
      • 16.4.2.3. By Application
  • 16.5. Argentina
    • 16.5.1. Pricing Analysis
    • 16.5.2. Market Share Analysis, 2024
      • 16.5.2.1. By Product Type
      • 16.5.2.2. By Age Group
      • 16.5.2.3. By Application
  • 16.6. Germany
    • 16.6.1. Pricing Analysis
    • 16.6.2. Market Share Analysis, 2024
      • 16.6.2.1. By Product Type
      • 16.6.2.2. By Age Group
      • 16.6.2.3. By Application
  • 16.7. Italy
    • 16.7.1. Pricing Analysis
    • 16.7.2. Market Share Analysis, 2024
      • 16.7.2.1. By Product Type
      • 16.7.2.2. By Age Group
      • 16.7.2.3. By Application
  • 16.8. France
    • 16.8.1. Pricing Analysis
    • 16.8.2. Market Share Analysis, 2024
      • 16.8.2.1. By Product Type
      • 16.8.2.2. By Age Group
      • 16.8.2.3. By Application
  • 16.9. U.K.
    • 16.9.1. Pricing Analysis
    • 16.9.2. Market Share Analysis, 2024
      • 16.9.2.1. By Product Type
      • 16.9.2.2. By Age Group
      • 16.9.2.3. By Application
  • 16.10. Spain
    • 16.10.1. Pricing Analysis
    • 16.10.2. Market Share Analysis, 2024
      • 16.10.2.1. By Product Type
      • 16.10.2.2. By Age Group
      • 16.10.2.3. By Application
  • 16.11. Russia
    • 16.11.1. Pricing Analysis
    • 16.11.2. Market Share Analysis, 2024
      • 16.11.2.1. By Product Type
      • 16.11.2.2. By Age Group
      • 16.11.2.3. By Application
  • 16.12. BENELUX
    • 16.12.1. Pricing Analysis
    • 16.12.2. Market Share Analysis, 2024
      • 16.12.2.1. By Product Type
      • 16.12.2.2. By Age Group
      • 16.12.2.3. By Application
  • 16.13. China
    • 16.13.1. Pricing Analysis
    • 16.13.2. Market Share Analysis, 2024
      • 16.13.2.1. By Product Type
      • 16.13.2.2. By Age Group
      • 16.13.2.3. By Application
  • 16.14. Japan
    • 16.14.1. Pricing Analysis
    • 16.14.2. Market Share Analysis, 2024
      • 16.14.2.1. By Product Type
      • 16.14.2.2. By Age Group
      • 16.14.2.3. By Application
  • 16.15. South Korea
    • 16.15.1. Pricing Analysis
    • 16.15.2. Market Share Analysis, 2024
      • 16.15.2.1. By Product Type
      • 16.15.2.2. By Age Group
      • 16.15.2.3. By Application
  • 16.16. India
    • 16.16.1. Pricing Analysis
    • 16.16.2. Market Share Analysis, 2024
      • 16.16.2.1. By Product Type
      • 16.16.2.2. By Age Group
      • 16.16.2.3. By Application
  • 16.17. Thailand
    • 16.17.1. Pricing Analysis
    • 16.17.2. Market Share Analysis, 2024
      • 16.17.2.1. By Product Type
      • 16.17.2.2. By Age Group
      • 16.17.2.3. By Application
  • 16.18. Malaysia
    • 16.18.1. Pricing Analysis
    • 16.18.2. Market Share Analysis, 2024
      • 16.18.2.1. By Product Type
      • 16.18.2.2. By Age Group
      • 16.18.2.3. By Application
  • 16.19. Indonesia
    • 16.19.1. Pricing Analysis
    • 16.19.2. Market Share Analysis, 2024
      • 16.19.2.1. By Product Type
      • 16.19.2.2. By Age Group
      • 16.19.2.3. By Application
  • 16.20. Australia
    • 16.20.1. Pricing Analysis
    • 16.20.2. Market Share Analysis, 2024
      • 16.20.2.1. By Product Type
      • 16.20.2.2. By Age Group
      • 16.20.2.3. By Application
  • 16.21. New Zealand
    • 16.21.1. Pricing Analysis
    • 16.21.2. Market Share Analysis, 2024
      • 16.21.2.1. By Product Type
      • 16.21.2.2. By Age Group
      • 16.21.2.3. By Application
  • 16.22. GCC Countries
    • 16.22.1. Pricing Analysis
    • 16.22.2. Market Share Analysis, 2024
      • 16.22.2.1. By Product Type
      • 16.22.2.2. By Age Group
      • 16.22.2.3. By Application

17. Market Structure Analysis

  • 17.1. Competition Dashboard
  • 17.2. Competition Benchmarking
  • 17.3. Market Share Analysis of Top Players
    • 17.3.1. By Regional
    • 17.3.2. By Product Type
    • 17.3.3. By Age Group
    • 17.3.4. By Application

18. Competition Analysis

  • 18.1. Competition Deep Dive
    • 18.1.1. MicroPort Scientific Corporation
      • 18.1.1.1. Overview
      • 18.1.1.2. Product Portfolio
      • 18.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.1.4. Sales Footprint
      • 18.1.1.5. Strategy Overview
        • 18.1.1.5.1. Marketing Strategy
        • 18.1.1.5.2. Product Strategy
        • 18.1.1.5.3. Channel Strategy
    • 18.1.2. Nipro Medical Corporation
      • 18.1.2.1. Overview
      • 18.1.2.2. Product Portfolio
      • 18.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.2.4. Sales Footprint
      • 18.1.2.5. Strategy Overview
        • 18.1.2.5.1. Marketing Strategy
        • 18.1.2.5.2. Product Strategy
        • 18.1.2.5.3. Channel Strategy
    • 18.1.3. Medtronic
      • 18.1.3.1. Overview
      • 18.1.3.2. Product Portfolio
      • 18.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.3.4. Sales Footprint
      • 18.1.3.5. Strategy Overview
        • 18.1.3.5.1. Marketing Strategy
        • 18.1.3.5.2. Product Strategy
        • 18.1.3.5.3. Channel Strategy
    • 18.1.4. Fresenius SE & Co KGaA
      • 18.1.4.1. Overview
      • 18.1.4.2. Product Portfolio
      • 18.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.4.4. Sales Footprint
      • 18.1.4.5. Strategy Overview
        • 18.1.4.5.1. Marketing Strategy
        • 18.1.4.5.2. Product Strategy
        • 18.1.4.5.3. Channel Strategy
    • 18.1.5. Terumo Medical Corporation
      • 18.1.5.1. Overview
      • 18.1.5.2. Product Portfolio
      • 18.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.5.4. Sales Footprint
      • 18.1.5.5. Strategy Overview
        • 18.1.5.5.1. Marketing Strategy
        • 18.1.5.5.2. Product Strategy
        • 18.1.5.5.3. Channel Strategy
    • 18.1.6. Getinge AB
      • 18.1.6.1. Overview
      • 18.1.6.2. Product Portfolio
      • 18.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
      • 18.1.6.4. Sales Footprint
      • 18.1.6.5. Strategy Overview
        • 18.1.6.5.1. Marketing Strategy
        • 18.1.6.5.2. Product Strategy
        • 18.1.6.5.3. Channel Strategy

19. Assumptions & Acronyms Used

20. Research Methodology